Kit for detecting early liver cancer

The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination to detect the expression levels of the two biomolecules in the plasma of a liver cancer individual to be diagnosed, early-stage liver cancer patients can be effectively screened, the combined detection is also sensitive to individuals with negative AFP antibody expression, the detection sensitivity is 94.9%, and the specificity reaches 89.3%. 本发明公开了一种用于检测早期肝癌的试剂盒，涉及生物医学技术领域，其通过检测个体样本中ACY1和GP73的水平来确定个体是否有肝癌状况。本发明将ACY1和GP73这2种分子作为一个组合，检测待确诊肝癌个体血浆中两种生物分子的表达水平，可以有效筛查肝癌早期患者，且该联合检测，对AFP抗体表达阴性的个体也较为灵敏，其检测灵敏度为94.9％，特异性达到89.3％。